(Q22252228)

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Children's Self-Reported Psychotic Symptoms and Adult Schizophreniform Disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Is cannabis use psychotogenic?

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Does cannabis use cause schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The continuity of psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Testing hypotheses about the relationship between cannabis use and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

A community survey of adverse effects of cannabis use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis dependence and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Deconstructing therapy outcome measurement with rasch analysis of a measure of general clinical distress: The Symptom Checklist-90-Revised

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Does cannabis use encourage other forms of illicit drug use?

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Five outpatient treatment models for adolescent marijuana use: a description of the Cannabis Youth Treatment Interventions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Effects of family history and place and season of birth on the risk of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis use and psychotic disorders: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Alcohol- and Drug-Use Disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis use and psychosis: a longitudinal population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The environment and schizophrenia: the role of cannabis use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis use and the risk of later schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Early adolescent cannabis exposure and positive and negative dimensions of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Tests of causal linkages between cannabis use and psychotic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The prevalence of psychotic symptoms among methamphetamine users.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Psychosis due to "skunk".

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis and mental health

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Data dredging, bias, or confounding

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Psychosocial factors and public health: a suitable case for treatment?

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Evidence of a cohort effect for age at onset of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis use and age at onset of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis as a risk factor for psychosis: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis and psychosis put in perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

What are the policy implications of the evidence on cannabis and psychosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis and psychosis. Is there epidemiological evidence for an association?

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The problem of detecting changes in the incidence of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Causal association between cannabis and psychosis: examination of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Stimulant psychosis: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Prevalence and correlates of self-reported psychotic symptoms in the British population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Self-reported psychotic symptoms in the general population

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

An Examination of the Factor Structure and Convergent and Discriminant Validity of the SCL-90R in an Outpatient Clinic Population

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The diagnosis and assessment of depression, mania, and psychosis by self-report

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021

The Limited Relevance of Drug Policy: Cannabis in Amsterdam and in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FJ.DRUGPO.2009.09.001

7 January 2021